175 related articles for article (PubMed ID: 32747505)
1. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4
Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD
J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.
Liu H; Jain R; Guan J; Vuong V; Ishido S; La Gruta NL; Gray DH; Villadangos JA; Mintern JD
J Exp Med; 2016 Aug; 213(9):1695-703. PubMed ID: 27503069
[TBL] [Abstract][Full Text] [Related]
3. MHC Class II Ubiquitination Regulates Dendritic Cell Function and Immunity.
Wilson KR; Jenika D; Blum AB; Macri C; Xu B; Liu H; Schriek P; Schienstock D; Francis L; Makota FV; Ishido S; Mueller SN; Lahoud MH; Caminschi I; Edgington-Mitchell LE; Villadangos JA; Mintern JD
J Immunol; 2021 Nov; 207(9):2255-2264. PubMed ID: 34599081
[TBL] [Abstract][Full Text] [Related]
4. Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83.
von Rohrscheidt J; Petrozziello E; Nedjic J; Federle C; Krzyzak L; Ploegh HL; Ishido S; Steinkasserer A; Klein L
J Exp Med; 2016 Aug; 213(9):1685-94. PubMed ID: 27503071
[TBL] [Abstract][Full Text] [Related]
5. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD
PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419
[TBL] [Abstract][Full Text] [Related]
6. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
Ishikawa R; Kajikawa M; Ishido S
Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
[TBL] [Abstract][Full Text] [Related]
7. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
[TBL] [Abstract][Full Text] [Related]
9. GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch MP; Meador LR; Metzger TC; Li H; Qiu S; Anderson MS; Hastings KT
J Immunol; 2020 Jun; 204(11):2877-2886. PubMed ID: 32269095
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
11. MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4
Logunova NN; Kriukova VV; Shelyakin PV; Egorov ES; Pereverzeva A; Bozhanova NG; Shugay M; Shcherbinin DS; Pogorelyy MV; Merzlyak EM; Zubov VN; Meiler J; Chudakov DM; Apt AS; Britanova OV
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13659-13669. PubMed ID: 32482872
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
13. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
[TBL] [Abstract][Full Text] [Related]
14. Low-Level MHC Class II Expression Leads to Suboptimal Th Cell Response, Increased Autoaggression, and Heightened Cytokine Inducibility.
Chen YT; Su YC; Chang ML; Tsai PF; Kung JT
J Immunol; 2017 Mar; 198(5):1928-1943. PubMed ID: 28108557
[TBL] [Abstract][Full Text] [Related]
15. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
16. MARCH ligases in immunity.
Liu H; Mintern JD; Villadangos JA
Curr Opin Immunol; 2019 Jun; 58():38-43. PubMed ID: 31063934
[TBL] [Abstract][Full Text] [Related]
17. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells.
Bensinger SJ; Bandeira A; Jordan MS; Caton AJ; Laufer TM
J Exp Med; 2001 Aug; 194(4):427-38. PubMed ID: 11514600
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitination of Major Histocompatibility Complex II Changes Its Immunological Recognition Structure.
Kozono Y; Kuramochi M; Sasaki YC; Kozono H
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069406
[TBL] [Abstract][Full Text] [Related]
20. MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells.
Oh J; Wu N; Baravalle G; Cohn B; Ma J; Lo B; Mellman I; Ishido S; Anderson M; Shin JS
J Exp Med; 2013 Jun; 210(6):1069-77. PubMed ID: 23712430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
